S
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Price:
92.3
CNY
2.12%
Market Closed
Market Cap:
¥57B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
Elringklinger AG
XETRA:ZIL2
|
DE |
|
JACCS Co Ltd
TSE:8584
|
JP |
|
G
|
Guangdong Huate Gas Co Ltd
SSE:688268
|
CN |
|
China Tungsten and Hightech Materials Co Ltd
SZSE:000657
|
CN |
|
China Suntien Green Energy Corp Ltd
SSE:600956
|
CN |
|
V2 Retail Ltd
NSE:V2RETAIL
|
IN |
Balance Sheet
Balance Sheet Decomposition
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Balance Sheet Decomposition is not available for
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Balance Sheet
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Currency: CNY
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
318
|
202
|
889
|
1 772
|
1 508
|
979
|
819
|
297
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
978
|
815
|
297
|
|
| Cash Equivalents |
318
|
202
|
889
|
1 772
|
1 508
|
1
|
4
|
0
|
|
| Short-Term Investments |
21
|
0
|
250
|
933
|
752
|
1 486
|
948
|
1 774
|
|
| Total Receivables |
515
|
579
|
324
|
116
|
269
|
158
|
137
|
152
|
|
| Accounts Receivables |
459
|
534
|
288
|
92
|
253
|
146
|
130
|
143
|
|
| Other Receivables |
56
|
45
|
36
|
24
|
16
|
12
|
7
|
9
|
|
| Inventory |
109
|
127
|
168
|
225
|
210
|
227
|
195
|
230
|
|
| Other Current Assets |
793
|
1 241
|
15
|
75
|
132
|
136
|
151
|
208
|
|
| Total Current Assets |
1 756
|
2 150
|
1 647
|
3 122
|
2 872
|
2 986
|
2 250
|
2 660
|
|
| PP&E Net |
1 207
|
1 179
|
1 185
|
1 314
|
1 428
|
1 512
|
1 598
|
1 577
|
|
| PP&E Gross |
1 207
|
1 179
|
1 185
|
1 314
|
1 428
|
1 512
|
1 598
|
1 577
|
|
| Accumulated Depreciation |
377
|
469
|
564
|
671
|
768
|
866
|
949
|
1 057
|
|
| Intangible Assets |
321
|
316
|
306
|
301
|
294
|
310
|
285
|
453
|
|
| Goodwill |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
111
|
106
|
122
|
109
|
1 020
|
1 140
|
|
| Other Long-Term Assets |
59
|
58
|
70
|
112
|
173
|
180
|
6
|
6
|
|
| Other Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
3 343
N/A
|
3 703
+11%
|
3 320
-10%
|
4 954
+49%
|
4 889
-1%
|
5 098
+4%
|
5 305
+4%
|
5 965
+12%
|
|
| Liabilities | |||||||||
| Accounts Payable |
8
|
10
|
22
|
21
|
16
|
16
|
22
|
35
|
|
| Accrued Liabilities |
54
|
66
|
69
|
49
|
52
|
52
|
160
|
160
|
|
| Short-Term Debt |
7
|
7
|
0
|
0
|
0
|
150
|
50
|
50
|
|
| Other Current Liabilities |
155
|
162
|
160
|
210
|
148
|
157
|
76
|
72
|
|
| Total Current Liabilities |
223
|
244
|
251
|
280
|
216
|
375
|
308
|
317
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
67
|
55
|
36
|
17
|
3
|
6
|
18
|
31
|
|
| Other Liabilities |
204
|
183
|
166
|
153
|
134
|
124
|
118
|
111
|
|
| Total Liabilities |
493
N/A
|
482
-2%
|
452
-6%
|
451
0%
|
347
-23%
|
493
+42%
|
409
-17%
|
397
-3%
|
|
| Equity | |||||||||
| Common Stock |
510
|
510
|
555
|
616
|
616
|
617
|
617
|
617
|
|
| Retained Earnings |
1 978
|
2 348
|
1 841
|
1 623
|
1 641
|
1 691
|
1 985
|
2 639
|
|
| Additional Paid In Capital |
361
|
363
|
472
|
2 273
|
2 301
|
2 309
|
2 303
|
2 310
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
12
|
10
|
11
|
|
| Other Equity |
0
|
0
|
1
|
10
|
17
|
1
|
2
|
14
|
|
| Total Equity |
2 850
N/A
|
3 221
+13%
|
2 868
-11%
|
4 503
+57%
|
4 542
+1%
|
4 606
+1%
|
4 896
+6%
|
5 568
+14%
|
|
| Total Liabilities & Equity |
3 343
N/A
|
3 703
+11%
|
3 320
-10%
|
4 954
+49%
|
4 889
-1%
|
5 098
+4%
|
5 305
+4%
|
5 965
+12%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
510
|
510
|
555
|
616
|
616
|
617
|
617
|
617
|
|
Switch to:
Switch to:
See Also
Discover More
